Status:
UNKNOWN
Debridement and Functional Endoscopic Sinus Surgery
Lead Sponsor:
St. Paul's Hospital, Canada
Conditions:
Chronic Rhinosinusitis (Diagnosis)
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Functional endoscopic sinus surgery (FESS) is the gold standard surgical intervention for management of patients with chronic rhinosinusitis (CRS). Synechiae formation in the middle meatus is the most...
Detailed Description
Purpose The purpose of this study is to assess the efficacy of post-FESS nasal debridements in the prevention of post-operative synechiae formation. Hypothesis There is no difference in short and lon...
Eligibility Criteria
Inclusion
- Over the age of 19;
- Have chronic sinus disease (CRS) and are scheduled to undergo sinus surgery on both sides of your nose for the first time.
Exclusion
- Unable to speak English;
- Are having surgery for the removal of a nasal tumor;
- Have a disorder of your immune system in which your body's immune system attacks itself (autoimmune disorder)
- Diagnosed with cystic fibrosis
- Have had sinus surgery in the past
- Are scheduled to have a procedure known as nasal septal reconstruction, without additional sinus surgery
Key Trial Info
Start Date :
June 22 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04093193
Start Date
June 22 2018
End Date
September 1 2021
Last Update
September 19 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
E.N.T Clinic, St. Paul's Hospital
Vancouver, British Columbia, Canada, V6Z 1Y6